What we study

Research

Understanding skeletal muscle health and disease through genetics, cellular biology, physiological responses, and therapeutic development.

Our approaches

From Genetics to Experimental Models

Illustration of DNA double helix

Human Genetics

Understanding the molecular basis of neuromuscular disease.

Illustration of a zebrafish

Zebrafish Models

Studying muscle development and disease in living systems.

Illustration of a mouse

Mouse Models

Investigating disease mechanisms and evaluating therapies.

Our approach

From disease mechanisms to therapeutics

Skeletal muscle function depends on the coordinated regulation of contractile architecture, protein homeostasis, cellular metabolism, and responses to physiological demands. Disruption of these interconnected processes can compromise muscle integrity and function across a wide spectrum of neuromuscular disorders.

Our research investigates the molecular mechanisms underlying skeletal muscle dysfunction, with a particular emphasis on how genetic variation and cellular responses to physiological stress influence disease onset, progression, and severity. Using human genetic studies, zebrafish and mouse models, molecular and cellular approaches, and therapeutic development, we aim to identify mechanisms that can be targeted to preserve and restore muscle function.

Sanger DNA sequencing traces from the laboratory publication
01

Genetic and molecular mechanisms

We study how genetic variation and changes in molecular pathways contribute to neuromuscular disorders, linking molecular findings to the biology of muscle disease.

Skeletal muscle fluorescence microscopy
02

Muscle structure and function

We investigate the processes that support muscle development, sarcomere organization, cellular maintenance, and force generation, and how these processes are altered in disease.

Electron microscopy of skeletal muscle sarcomeres from published KLHL41 study
03

Experimental models

We use zebrafish, mice, and cellular models to examine disease mechanisms in biological context and evaluate changes in muscle structure and performance.

AAV gene replacement and small molecule therapy illustration
04

Therapeutic Development: Gene Therapy and Small Molecules

We develop and evaluate gene therapies and small-molecule approaches to restore muscle function, translating mechanistic discoveries into preclinical therapeutic strategies.

Why this matters

Our research connects fundamental questions in muscle biology with the long-term goal of developing better treatments for people affected by neuromuscular diseases.

Explore our publications →